![Matthew Foster](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
Matthew Foster is currently the Chief Restructuring Officer at Allena Pharmaceuticals, Inc. since 2022.
Prior to this, he held the position of Chief Restructuring Officer at Argos Therapeutics, Inc.
Aktive Positionen von Matthew Foster
| Unternehmen | Position | Beginn |
|---|---|---|
| ALLENA PHARMACEUTICALS, INC. | Corporate Officer/Principal | 02.09.2022 |
Ehemalige bekannte Positionen von Matthew Foster
| Unternehmen | Position | Ende |
|---|---|---|
| ARGOS THERAPEUTICS, INC. | Corporate Officer/Principal | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
3
Beziehungen ersten Grades
2
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
Argos Therapeutics, Inc.
 Argos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes personalized immunotherapies for the treatment of cancer and infectious diseases | Health Technology |
Allena Pharmaceuticals, Inc.
 Allena Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and retails drugs through online | Health Technology |
